Irinotecan trials for Pancreatic Ductal Adenocarcinoma

All Irinotecan trials · All Pancreatic Ductal Adenocarcinoma trials

Phase breakdown

Recruiting trials studying Irinotecan for Pancreatic Ductal Adenocarcinoma

• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
  NCT04657068 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 164 locations
• A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
  NCT07024615 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
  NCT06219941 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 52 locations
• MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
  NCT06586515 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 104 locations

Common questions

How many trials study Irinotecan for Pancreatic Ductal Adenocarcinoma?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.